# Daily report — trading day 2026-09-29 (Tuesday)

*Written by the 19:15Z scheduled run (2:15 PM CT), invoked with **prompt v15**. Broker read 19:15–19:17Z: **zero drift** in both books. Every P&L figure comes from the broker (`get_realized_pnl`, `get_equity_orders`).*

## 1. Day track (PAPER)
- **Opening range (QQQ, 09:30–09:35 ET, 1-min bars):** high 740.58 / low 737.67, open 740.13 → close 737.86. Body was 78% of the range, so the signal was **SHORT** (vehicle PSQ).
- **Paper trade:** entry 737.065 (signal), stop 740.58, 77 PSQ shares. **Closed at 16:00Z by the chop rule** (past 12:00 ET with |R| < 0.5): **+0.01R, −$1.54 paper.**
- **Running paper tally:** 10 paper days, 8 signals: −1, −1, −1, +6.48, +1.35, −1, +2.63, +0.01 = **+6.47R** total. That meets the day and signal counts `graduate()` needs, so Monday's calibration decides the phase. **Still PAPER until then.** No run promotes the phase mid-week.

## 2. Positions (after today's trades)
| Name | Shares | Entry | Mark ~19:16Z | P/L | Grade (19:08Z report) | Why we own it |
|---|---|---|---|---|---|---|
| FCX | 8.630265 | 71.84 | 70.91 | −1.3% | B 10/12 #33 (still inside the top-25% hold bar) | Copper leader dip. Held on thesis; it will be sold if the rank leaves the top 25% (GRADE EXIT) |
| DE | 0.930369 | 681.45 | 678.71 | −0.4% | A+ 12/12 #11 | Ag-equipment leader bought on an RSI2 dip today |
| ABBV | 2.408819 | 263.61 | 263.78 | +0.1% | A+ 12/12 #13 | Pharma leader bought on a 21-EMA pullback today |
| **TGT** | 3.980133 | 157.03 | 157.10 | ±0 | A+ 11/12 #15 | **NEW this run.** Retail leader on a 21-EMA pullback |

Options: none. No stops on the swing book (HARD RULE 5). None of the names is near green-enough for a native trail yet.

## 3. Actions today (all autonomous, all `placed_agent: agentic`)
1. **BUY DE $634** — 17:46Z, 0.930369 sh @ 681.45. RSI2 dip on an A+ name. Taken on the first run after the equity KILL pause was lifted.
2. **BUY ABBV $635** — 18:01Z, 2.408819 sh @ 263.61. 21-EMA pullback, A+. News check came back intact: JUVMO FDA approval 09-28, RINVOQ EU approval; analyst mean price target $280.
3. **SELL MRK (take-profit)** — 19:15:55Z, all 4.199975 sh @ **149.1201**, fee $0.02. **Realized +$6.30 (+1.0%)**, per the broker.
   - **Why:** the 19:08Z report fired `SELL / TAKE-PROFIT`, with RSI2 at 73.4 on a green position.
   - I re-checked this on the live quote: price 149.13 (above entry 147.62), and RSI2 recomputed with that price as the latest close was about 75.6, still ≥70.
   - The rule is Connors-pure: the RSI2 cross *is* the exit, and there is no magnitude test.
   - It was bought on 09-25 at 147.62, so it was a 2-session hold. Small round trips like this are the strategy's measured edge.
4. **BUY TGT $625** — 19:16:41Z, 3.980133 sh @ **157.0299**. The MRK proceeds reopened one slot.
   - **Sizing:** equity deployable = unleveraged BP $1,461.46 − 5% reserve $167.03 − options bucket $668.11 = **$626.32**. With 1 open slot of the 4-slot target, size is $625: above the $600 minimum and 19% of the account, under the 30% cap.
   - **Freshness gate (all four passed):**
     - Quote from 19:16:36Z, 5 seconds before the order.
     - Trigger re-computed on the live 157.10: 0.42% *below* the 21-EMA (157.76), above the 50-SMA (154.52), RSI2 36.3. That is a valid 21-EMA pullback.
     - News check done this run at 19:16Z.
     - Grade A+ #15 from the 19:08Z report, 8 minutes old.
   - **Thesis:** intact, with margin on watch. $1.16 dividend declared 09-23. Price cuts on about 2,000 items ahead of the holiday season are a margin risk, but the stock rose +0.6% on the day they were announced. Consensus Hold, mean price target $162.76, above spot. Next earnings are about mid-November, outside the hold window.
   - **Note:** this re-enters a name the book took profit on at 160.18 on 09-28. The rules are signal-based, and TGT re-triggered on the pullback, so this is not a chase.

## 4. Skipped
- **JNJ** (A+ #22, 21-EMA pullback): **no entry.** It reports earnings 2026-10-13, inside the hold window, which is an absolute bar.
- **Options, re-graded on this run's quotes** (19:14–19:16Z, 2026-10-30 board, 31 DTE):
  - TGT 157.5C (bid 5.35 / ask 5.90): spread 9.8% passes, and at $590 it fits the $668 bucket. It **fails the payoff gate:** at the $164.44 target it is worth 6.94 against a 5.90 cost, **+17.6%, below the 20% bar.**
  - ABBV 265C: spread 24.1%, and at $860 it exceeds the bucket. **Fails.**
  - DE 690C: spread 31.5%, OI 37, $2,350. **Fails.**
  - **No options entry.**
- **Excluded B/C RSI2 dips** from the report, not graded as setups: ROKU, PSX, REGN, IBKR, NUE, CRM, IWM, KO, OXY, HPQ. PSX and OXY are also oil names under the sector steer.

## 5. Sleeve state
- Account total ~$3,340.55. Unleveraged BP was $1,461.46 after the MRK sale and is ~$836 after TGT. **No margin.**
- 5% operational reserve: $167.03.
- **Options bucket:** $668.11, $0 at risk. Options realized $0.00 against the −$400 cap. Options entries today: 0 of 3.
- **Equity entries today: 3 of 3 used** (DE, ABBV, TGT). **Slots: 4 of 4 (target filled).**
- Equity realized today: **+$6.30** (MRK).

## 6. Calibration
No change this week. The calibration regime starts 2026-09-25, in-regime closes are far below n=20, and `recommend()` only reports at that size. The equity KILL pause was lifted 2026-09-29 on Ryan's live turn.

## 7. Tomorrow's watchpoints
- **Take-profit:** RSI2 ≥70 on any green name. ABBV is closest to green (+0.1%); its target of 266.28 is an estimate.
- **GRADE EXIT:** FCX is B #33. If its rank leaves the top 25% (about #59 of 236), it is sold green or red.
- **Day track:** the Monday 10-05 calibration runs `day_track.graduate()` on 10 days / 8 signals / +6.47R.
- **JNJ:** earnings 10-13, so it stays excluded until after the print.
- Equity entries are throttled to 3 per day. Tomorrow's budget resets at the 09:30 ET open.
